Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Gel for Breakthrough and Neuropathic Pain in Knee OA
NCT01383954Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2011
- Primary completion
- Aug 2012
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Voltaren gel in knee osteoarthritis (OA), sponsored by Brigham and Women's Hospital. Primary endpoints: Percent Change From Baseline in Pain Score During Week 1 and Percent Change From Baseline in Pain Score During Week 2. Started Jun 2011; status: completed.
02
Drugs
Voltaren gel
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01383954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01383954.